Phase 2 Type 2 Diabetes Trial, Not Yet Recruiting NCT06495814 Sponsor: Fengmei Lian Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 2 Type 2 Diabetes Trial, Not Yet Recruiting

NCT06495814
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 65 years old (inclusive)
  • People whose waist measurement meets the central obesity threshold set out in Chinese obesity guidelines (2019) (confirm with trial site)
  • People whose blood sugar test results meet the criteria for impaired glucose tolerance (a pre-diabetes condition where blood sugar is higher than normal but not yet at diabetes level) according to Chinese diabetes guidelines (2020) (confirm with trial site)
  • People who have been newly diagnosed with type 2 diabetes (diagnosed less than 3 months ago) and whose waist measurement meets the central obesity threshold in Chinese obesity guidelines (2019) (confirm with trial site)
  • People who meet the World Health Organization's criteria for being considered healthy
  • People whose blood sugar test results place them in either a high-risk or low-risk group for impaired glucose tolerance, based on a risk prediction model used in this study (confirm with trial site)
  • People who are willing to take part and sign a consent form

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been regularly taking blood sugar-lowering medications in the past three months
  • People who have type 1 diabetes, gestational diabetes (diabetes during pregnancy), secondary diabetes, or other specific types of diabetes
  • People who have complications related to diabetes
  • People with a poorly controlled thyroid condition (either overactive or underactive thyroid) caused by a hormonal disorder
  • People with blood pressure that is very difficult to control — either too high (top number at or above 200 mmHg or bottom number at or above 110 mmHg) or too low (top number at or below 90 mmHg or bottom number at or below 60 mmHg)
  • People who have an active serious infection, severe anaemia, or a very low white blood cell count at the time of screening
  • People with other serious illnesses, such as an active or untreated cancer, or a cancer that has been in remission for less than 5 years
  • People with serious structural heart disease (such as congenital heart disease, rheumatic heart disease, or certain types of enlarged heart) with a heart function rating above Grade III (confirm with trial site)
  • People who have had a heart bypass or angioplasty procedure, or a stroke (any type), within the past 6 months
  • People with severely reduced liver or kidney function, based on specific blood test results (confirm with trial site)
  • People with very high fasting triglyceride (a type of blood fat) levels above 5.6 mmol/L
  • Women who are pregnant or breastfeeding, or women who are of childbearing age and not using effective contraception
  • People currently taking part in any other clinical trial
  • People with a history of alcohol dependency or long-term misuse of drugs
  • People with a history of mental illness who are unable to cooperate with the research team
  • People with any previously diagnosed long-term condition affecting major body systems, such as blood disorders, respiratory conditions, cardiovascular disease, or liver or kidney problems
  • Anyone the researchers consider unsuitable to participate for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026

Contact this trial

Phone: 13651249262

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Fengmei Lian
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
30 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

incidence of diabetes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov